Abstract
Na+, K+-ATPase activity was measured in synaptic plasma membrane from cerebral cortex of Wistar rats subjected to experimental phenylketonuria, i.e., chemical hyperphenylalaninemia induced by subcutaneous administration of 5.2 μmol phenylalanine /g body weight (twice a day) plus 0.9 μmol p-chlorophenylalanine /g body weight (once a day). The treatment was performed from the 6th to the 14th postpartum day and rats were killed 12 h after the last injection. Synaptic plasma membrane from cerebral cortex was prepared by a discontinuous density sucrose gradient for Na+, K+-ATPase activity determination. The results showed that the enzyme activity was decreased by 30% in animals subjected to experimental phenylketonuria when compared to control. Thein vitro effects of the drugs on Na+, K+-ATPase activity were also investigated. Phenylalanine and p-chlorophenylalanine inhibited the enzyme activity and this inhibition was reversed by alanine. In addition, competition between phenylalanine and p-chlorophenylalanine for binding to the enzyme was observed, suggesting a common binding site for these substances. Our results suggest that reduction of Na+, K+-ATPase activity may be one of the mechanisms related to the brain dysfunction observed in human PKU.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bertorello, A.M. and Kats, A.L. (1995). Regulation of Na+-K+-Pump activity: pathways between receptors and effectors.NIPS,10:253–259.
Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal. Biochem. 72:248–254.
Carfagna, M.A. and Muhoberac, B.B. (1993). Interaction of tricyclic drug analogs with synaptic plasma membranes: structure-mechanism relationships in inhibition of neuronal Na+/K+-ATPase activity.Mol. Pharmacol. 44:129–141.
Chan, K.M., Delfert, D., and Junger, K.D. (1986). A direct colorimetric assay for Ca2+-stimulated ATPase activity.Anal. Biochem. 157:375–380.
Chevillard, C., Cárdenas, M.L., and Cornish-Bowden, A. (1993). The competition plot: a simple test of whether two reactions occur at the same active site.Biochem. J. 289:599–604.
Cousin, M.A., Nicholls, D.G., and Pocock, J.M. (1995). Modulation of ion gradients and glutamate release in cultured cerebellar granule cells by ouabain.J. Neurochem. 64:2097–2104.
Delvalle, J.A., Dienel, G., and Greengard, O. (1978). Comparation of α-methylphenylalanine and p-chlorophenylalanine as inducers of chronic hyperphenylalaninemia in developing rats.Biochem. J. 170:449–459.
Dwivedy, A.K., and Shah, S. (1981). Effect of hyperphenylalaninemia on Na+, K+-ATPase in rat brain.Exp. Neurol. 74:924–929.
Hommes, F.A., and Matsuo, K. (1987). On a possible mechanism of abnormal brain development in experimental hyperphenylalaninemia.Neurochem. Int. 11:1–10.
Hommes, F.A. (1991). On the mechanism of permanent brain dysfunction in hyperphenylalaninemia.Biochem. Med. Metab. Biol. 46:277–287.
Jones, D.H., and Matus, A.I. (1974). Isolation of synaptic plasma membrane from brain by combination flotation-sedimentation density gradient centrifugation.Biochim. Biophys. Acta,356:276–287.
Lane, J.D., Schone, B., Langenbeck, U., and Neuhoff, V. (1980). Characterization of experimental phenylketonuria augmentation of hyperphenylalaninemia with α-methylphenylalamine and p-chlorophenylalanine.Biochim. Biophys. Acta. 627:144–156.
Lees, G.J. (1991). Inhibition of sodium-potassium-ATPase: a potentially ubiquitous mechanism contributing to central nervous system neuropathology.Brain Res. Rev. 16:283–300.
Lees, G.J. (1993). Contributory mechanisms in the causation of neurodegenative disorders.Neuroscience,54: 287–322.
Lees, G.J., Lehmann, A., Sandberg, M., and Hamberg, H. (1990). The neurotoxicity of ouabain, a sodiumpotassium ATPase inhibitor, in the rat hippocampus.Neurosc. Lett. 120:159–162.
Lees, G.J., and Leong, W. (1995). Brain lesions induced by specific and non-specific inhibitors of sodiumpotassium ATPase.Brain Res. 649:225–233.
Lipton, M.A., Gordon, R., Guroff, G., and Udenfriend, S. (1967). p-Chlorophenylalanine induced chemical manisfestations of phenylketonuria in rats.Science,156:248–250.
Pontes, Z.L., Oliveira, L., Bavaresco, C.S., Streck, E.L., Dutra-Filho, C.S.D., Wajner, M., Wannmacher, C.M.D., and Wyse, A.T.S. (1999). Proline administration decreases Na+, K+-ATPase activity in the synaptic plasma membrane from cerebral cortex of rats.Metab. Brain Dis. 14:265–272.
Scriver, C.R., Kaufman, S., Eisensmith, R.C., and Woo, S.L.C. The hyperphenylalaninemia: Scriver, C.R., Beaudet, A.L., Sly, W.S., and Valle, D. (Eds.) (1995). The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill, Inc., New York, 7 th, 1015–1076.
Silva, C.S., Parolo, E., Streck, E., Wajner, M., Wannmacher, C.M.D., and Wyse, A.T.S. (1999).In vitro inhibition of Na+, K+-ATPase activity from rat cerebral cortex by guanidino compounds accumulating in hyperargininemia.Brain Res. 838:78–84.
Tsakiris, S. and Deliconstantinos, G. (1983). Influence of phosphatidylserine on (Na++K+)-stimulated ATPase and acetylcholinesterase activities of dog brain synaptosomal plasma membranes.Biochem. J. 220:307–310.
Van der Hijden, H.T., Schuurmans Stekhoven, F.M., and De Pont, J.J. (1989). Sidedness of the effect of amines on the steady-state phosphorylation level of reconstituted Na+/K+-ATPase.Biochim. Biophys. Acta. 987:75–82.
Winick, M. and Noble, R. (1965). Quantitative changes in DNA, RNA, and protein during prenatal and posnatal growth in the rat.Develop. Biol. 12:451–466.
Wyse, A.T.S., Wajner, M., Brusque, A.M., Bolognesi, G., and Wannmacher, C.M.D. (1995a). Na+, K+-ATPase activity in the synaptic plasma membrane from cerebral cortex of rats subjected to chemically induced phenylketonuria.Med. Sci. Res. 23:261–262.
Wyse, A.T.S., Sarkis, J.J.F., Cunha-Filho, J.S., Teixeira, M., Schetinger, R.M.C., Wajner, M., and Wannmacher, C.M.D. (1995b). ATP diphosphohydrolase activity in synaptosomes from cerebral cortex of rats subjected to chemically induced phenylketonuria.Braz. J. Med. Biol. Res. 28:643–649.
Wyse, A.T.S., Wajner, M., and Wannmacher, C.M.D. (1998). Kinetics of alanine reversal on the inhibition of Na+, K+-ATPase activity by phenylalanine and phenyllactate in the synaptic plasma membrane from the cerebral cortex of rats.Med. Sci. Res. 26:141–143.
Wyse, A.T.S., Noriler, M.E., Borges, L.F., Floriano, P.J., Silva, C.G., Wajner, M., and Wannmacher, C.M.D. (1999). Alanine prevents the decrease of Na+, K+-ATPase in experimental phenylketonuria.Metab. Brain Dis. 14:95–101, 1999.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Streck, E.L., Edom, P.T., Noriler, M.E. et al. Effect of phenylalanine and p-chlorophenylalanine on Na+, K+-ATPase activity in the synaptic plasma membrane from the cerebral cortex of rats. Metab Brain Dis 15, 105–114 (2000). https://doi.org/10.1007/BF02679977
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02679977